MGNX — MacroGenics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for MacroGenics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	273	244	154	230	202
Net Total Accounts Receivable
Net Total Receivables	23.1	10.4	56.2	10.4	4.31
Total Inventory
Prepaid Expenses
Total Current Assets	313	280	222	251	217
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	61.4	54.3	56.9	45.7	42.6
Other Long Term Assets
Total Assets	379	335	280	298	262
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	50.7	74.6	48.6	56.1	55.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	82.9	95.6	138	146	146
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	296	240	142	153	116
Total Liabilities & Shareholders' Equity	379	335	280	298	262
Total Common Shares Outstanding